Massachusetts Financial Services Co. MA Has $388.89 Million Stake in Ventas, Inc. $VTR

Massachusetts Financial Services Co. MA trimmed its holdings in shares of Ventas, Inc. (NYSE:VTR) by 0.3% in the third quarter, according to its most recent filing with the SEC. The firm owned 5,556,297 shares of the real estate investment trust’s stock after selling 14,174 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Ventas were worth $388,885,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. True Wealth Design LLC lifted its stake in shares of Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after acquiring an additional 405 shares during the period. ORG Partners LLC increased its position in shares of Ventas by 76.1% in the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 197 shares in the last quarter. Wilmington Savings Fund Society FSB raised its position in shares of Ventas by 65.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 180 shares during the period. Ameritas Advisory Services LLC acquired a new position in shares of Ventas in the second quarter valued at approximately $33,000. Finally, Golden State Wealth Management LLC increased its holdings in Ventas by 52.7% during the 2nd quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 185 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Stock Up 1.9%

NYSE:VTR opened at $78.40 on Monday. Ventas, Inc. has a twelve month low of $58.22 and a twelve month high of $81.89. The firm has a market capitalization of $36.82 billion, a price-to-earnings ratio of 150.76, a price-to-earnings-growth ratio of 1.94 and a beta of 0.78. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. The stock’s 50 day moving average price is $78.44 and its two-hundred day moving average price is $71.91.

Ventas (NYSE:VTR) last released its quarterly earnings data on Wednesday, October 29th. The real estate investment trust reported $0.88 EPS for the quarter, beating the consensus estimate of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the firm posted $0.80 EPS. The firm’s revenue for the quarter was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Equities research analysts expect that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st were given a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Wednesday, December 31st. Ventas’s dividend payout ratio (DPR) is 369.23%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on VTR shares. Wells Fargo & Company boosted their price target on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Jefferies Financial Group restated a “buy” rating and issued a $93.00 target price on shares of Ventas in a research note on Monday, December 15th. KeyCorp upped their price target on Ventas from $70.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Finally, Scotiabank boosted their price objective on shares of Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $81.63.

Insider Activity

In related news, CEO Debra A. Cafaro sold 317,258 shares of Ventas stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $74.24, for a total transaction of $23,553,233.92. Following the completion of the transaction, the chief executive officer owned 1,145,695 shares in the company, valued at approximately $85,056,396.80. This trade represents a 21.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Peter J. Bulgarelli sold 3,924 shares of the business’s stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $75.00, for a total value of $294,300.00. Following the transaction, the chief executive officer directly owned 112,564 shares in the company, valued at approximately $8,442,300. This trade represents a 3.37% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 494,005 shares of company stock valued at $37,132,767 in the last quarter. Company insiders own 0.80% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.